QQ客服 官方微博 反馈留言

浏览/检索结果: 共6条，第1-6条 帮助 限定条件 发表日期：2018    内容类型：会议论文     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Global clinical trials validating bioequivalence with China-manufactured trastuzumab biosimilar, HLX02, and trastuzumab 会议论文 作者:  Zhang, Q.;  Xu, B.;  Zhang, Q.;  Sun, T.;  Li, W. 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 Global clinical trials validating bioequivalence with China-manufactured trastuzumab biosimilar, HLX02, and trastuzumab 会议论文 作者:  Xu, B.;  Luk, A.;  Liu, S.;  Jiang, W.;  Liu, E. 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 Clinical outcomes in high bleeding risk patients undergoing complex PCI with the Xience everolimus eluting stent: a patient-level pooled analysis from four Xience post-approval trials 会议论文 作者:  Vogel, Birgit;  Claessen, Bimmer;  Baber, Usman;  Sorrentino, Sabato;  Zhao, Weiying 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05 Efficacy, safety and tolerability of neratinib-based therapy in patients from Asia with metastatic HER2+breast cancer and other solid tumors: A pooled analysis of 6 clinical trials 会议论文 CANCER RESEARCH, 2018-02-01 作者:  Xu, Binghe;  Kim, Sung-Bae;  Inoue, Kenichi;  Shen, Zhen-Zhou;  Lee, Ju RueyJiuan 收藏  |  浏览/下载：14/0  |  提交时间：2020/01/03 Global clinical trials validating bioequivalence with China-manufactured trastuzumab biosimilar, HLX02, and trastuzumab 会议论文 ANNALS OF ONCOLOGY, 2018-11-01 作者:  Zhang, Q.;  Xu, B.;  Sun, T.;  Li, W.;  Teng, Y. 收藏  |  浏览/下载：8/0  |  提交时间：2020/01/03 The Attitudes of Patients with Nonalcoholic Fatty Liver Disease Towards Participation in Placebo-Controlled Clinical Trials: Results from a Multicenter Survey 会议论文 Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, NOV 09-13, 2018 作者:  Huang, Rui;  Rao, Huiying;  Lv, Fangfang;  Nan, Yuemin;  Ren, Wanhua 收藏  |  浏览/下载：13/0  |  提交时间：2019/12/31